Dr. Humam W. Farah, MD

Dr. Farah practices at Blessing Hospital in Quincy, Illinois, part of Blessing Health System.

Dr. Farah's NPI, 1306880141, was assigned on June 15, 2006. Dr. Farah holds Missouri license 111211.

Dr. Farah's primary practice is Blessing Hospital, at 1005 Broadway St, Quincy, IL 62301 in Adams County. The practice phone is (217) 223-1200.

Dr. Farah's primary practice is Blessing Hospital in Quincy, Illinois, part of Blessing Health System. Dr. Farah is also affiliated with Barnes-Jewish Hospital. The medical group on file is Blessing Hospital. Dmand AI also links Dr. Farah to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Farah's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farah practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Farah's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Farah is licensed in Missouri.

CMS data shows 7,546 Medicare services from Dr. Farah across 15 procedure codes in 2024, for 1,307 Medicare patients. Medicare paid $368,210 for them.

CMS counts 1,307 Medicare patients who saw Dr. Farah in 2024. The largest group is 65 to 74, with 585 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farah's median patient age at 73, with 53% women.

In 2024, Dr. Farah wrote 6,289 Medicare Part D claims for 755 patients. 47% of them were for generic drugs. CMS names the drug for 6,087 of them, across 62 drugs with 11 or more claims each, at $7,403,081 in total drug cost. In 2023, CMS named 4,827 claims across 50 drugs.

Dr. Farah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Farah, published from 2013 to 2024. Dr. Farah's most frequent co-authors are Mark Louis Brantly, MD, Christopher Reid Brown, MD and Cynthia Diane Brown, MD.

Dmand AI links Dr. Farah to 3 clinical trials. Conditions studied include alpha 1-Antitrypsin Deficiency, Subcutaneous Emphysema and Idiopathic Pulmonary Fibrosis.

CMS Open Payments shows 2,017 general payments to Dr. Farah from 53 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 77% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $361,108. It also lists 1 research payment totaling $150 in 2021.